1-(5-甲基吡啶-2-基)哌啶-4-胺

pro_cas
252578-19-1 ;596817-94-6
pro_cdbregno
CCD00767560
pro_formula
C11 H17 N3
pro_molWeight
191.276

Company_information Contact BusinessType CountryRegion Inquiry

Accel Pharmtech LLC

596817-94-6;252578-19-1, 1-(5-甲基吡啶-2-基)哌啶-4-胺, 1-(5-METHYLPYRIDIN-2-YL)-4-PIPERIDINAMINE

732 993 9004

http://www.accelpharmtech.com

Others
US Inquiry

BOC Sciences

596817-94-6;252578-19-1, 1-(5-甲基吡啶-2-基)哌啶-4-胺, 1-(5-METHYLPYRIDIN-2-YL)-4-PIPERIDINAMINE

1-631-485-4226

http://www.bocsci.com

TradingCompany
US Inquiry

重庆化学利华制药有限公司

252578-19-1;596817-94-6, 1-(5-甲基吡啶-2-基)哌啶-4-胺, 1-(5-METHYLPYRIDIN-2-YL)-4-PIPERIDINAMINE

86 2367770219

http://www.chemieliva.com

TradingCompany
CN Inquiry

武汉旭睿生化科技有限公司

596817-94-6;252578-19-1, 1-(5-甲基吡啶-2-基)哌啶-4-胺, 1-(5-METHYLPYRIDIN-2-YL)-4-PIPERIDINAMINE

[86] 2784232005

http://www.daybiochem.com

TradingCompany
CN Inquiry

上海欧堃化学有限公司

596817-94-6;252578-19-1, 1-(5-甲基吡啶-2-基)哌啶-4-胺, 1-(5-METHYLPYRIDIN-2-YL)-4-PIPERIDINAMINE

86 21 6871 2331

http://www.AOKchem.com

TradingCompany
CN Inquiry

苏州诺行贸易有限公司

596817-94-6;252578-19-1, 1-(5-甲基吡啶-2-基)哌啶-4-胺, 1-(5-METHYLPYRIDIN-2-YL)-4-PIPERIDINAMINE

+86 512 65816829, 61978430, 60635156

http://www.rovathin.com.cn

TradingCompany
CN Inquiry

Advanced Building Blocks Corporation

596817-94-6;252578-19-1, 1-(5-甲基吡啶-2-基)哌啶-4-胺, 1-(5-METHYLPYRIDIN-2-YL)-4-PIPERIDINAMINE

858 621 3550

http://www.abblocks.com

TradingCompany
US Inquiry

宁波菲克斯药业有限公司

596817-94-6;252578-19-1, 1-(5-甲基吡啶-2-基)哌啶-4-胺, 1-(5-METHYLPYRIDIN-2-YL)-4-PIPERIDINAMINE

86 (0) 574 62378411

http://www.facus-pharma.com

TradingCompany
CN Inquiry

北京奥克苏医药科技有限公司

252578-19-1;596817-94-6, 1-(5-甲基吡啶-2-基)哌啶-4-胺, 1-(5-METHYLPYRIDIN-2-YL)-4-PIPERIDINAMINE

86 10 61251018

http://www.aokesu.com

TradingCompany
CN Inquiry

Wonda Science

596817-94-6;252578-19-1, 1-(5-甲基吡啶-2-基)哌啶-4-胺, 1-(5-METHYLPYRIDIN-2-YL)-4-PIPERIDINAMINE

514 581 6866

http://www.wondasci.com

TradingCompany
CA Inquiry

* If the product has intellectual property rights, a license granted is must or contact us.